Vaginal Herpes Zoster While Under Treatment for Relapsing-Remitting Multiple Sclerosis With Diroximel Fumarate

Multiple sclerosis (MS) is an autoimmune demyelinating disorder that disproportionately affects middle-aged women, and capable of resulting in severe disability. However, the use disease-modifying therapies has profoundly contributed to improvement morbidity disorder. Diroximel fumarate (DRF) a second-generation drug seen success treatment relapsing-remitting MS (RRMS). While its relatively mild side effects gastrointestinal discomfort are known, less common complications often missed clinical settings. This includes susceptibility opportunistic infections. In this case report, we describe patient who experienced lymphopenia, recurrent yeast infections, labial shingles while on medication. highlights rare immunomodulator, DRF.